@lucieberko.bsky.social
MD. PhD. Psychiatrist and researcher at GHU Paris psychiatrie & neurosciences - Psychedelics, consciousness and psychiatry https://lucie-berkovitch.fr https://scholar.google.com/citations?user=7ShQ
Mon site internet personnel est en ligne !
lucie-berkovitch.fr/fr
Il rassemble mes publications, interventions en congrès ou dans les médias, et les éléments principaux de mon parcours🎢
🌈 Vous verrez, je me suis fait plaisir avec les liens cliquables qui ont une petite touche #psychédélique !
My personal website is now live!
lucie-berkovitch.fr/en
It showcases my publications, talks, and media interviews, as well as the key milestones of my career 🎢
🌈 You'll see that I had fun with the clickable links, which have a slightly #psychedelic touch!
Et au passage je vous souhaite à toutes et à tous une très belle année 2026 ✨
🎧 Bonne écoute !
L'occasion d'aborder les contrevérités circulant sur ces substances et de souligner leur potentiel thérapeutique 💊
Un grand merci à @quentinlafay.bsky.social, @juliettemouellic.bsky.social et à toute l'équipe !
🌚 Questions du soir, bonjour ! @questionsdusoir.bsky.social
🎙️ Emission de rentrée consacrée aux #psychédéliques en direct hier sur @franceculture.fr en compagnie de @vincent-verroust.bsky.social de la Société psychédélique française @psychedelique-fr.bsky.social
www.radiofrance.fr/francecultur...
💊 We conclude that ketamine may induce psychotic-like symptoms by disrupting consciousness.
📣 Please enjoy, share, and give feedback!
Many thanks to my colleagues who supported me in this epic tale!
Raphaël Gaillard, @standehaene.bsky.social, @thomasandrillon.bsky.social and Alexandre Salvador
👀 We used a visual masking paradigm and found that healthy volunteers under ketamine were less able to perceive a digit.
🧠 These effects were related to a decreased early brain activity in EEG (N1) and to the intensity of experienced psychotic-like symptoms.
" #Ketamine disrupts #consciousness in healthy participants in relation with #psychotic-like symptoms"
🥸 This is the title of our last preprint @biorxiv-neursci.bsky.social giving some insights on how ketamine at subanesthetic doses mimicks psychosis symptoms!
www.biorxiv.org/content/10.1...
Thank you so much @haunted.audio, it is an amazing series!
This amazing series by Tim Hayward and Richard Ward @haunted.audio (🙏🙏🙏) also featured renowned neuroscientists such as @christimmermann.bsky.social, @katrinpreller.bsky.social, Gul Dölen, as well as nurses, historians, philosophers, sociologists, etc.
Enjoy! 🎧
In the first episode, I explain what is specific about psychedelics as treatment in psychiatry.
In last episode, dealing about the future of psychedelics, I talk about the possible dissociation between the psychedelic experience and the therapeutic effects:
www.bbc.co.uk/programmes/m...
🎙️ I am very proud to have participated (with a very strong French accent) to the BBC Radio 4 program Understand entitled "The Trip", about the science, culture, history and future of psychedelics 🌈
www.bbc.co.uk/programmes/m...
A few moments from our ongoing MESEC 2025 Workshop (‘Centering Experience in Mental Health: Uniting Psychiatry and Consciousness Science’) at the beautiful Lago di Bolsena!
@lucieberko.bsky.social
@tehseennoorani.bsky.social
🚨 New article in #NCONSC
Disruption of consciousness depends on insight in obsessive-compulsive disorder and on positive symptoms in schizophrenia
academic.oup.com/nc/article/2...
@lucieberko.bsky.social
#consciousness
🧠🧪
🙏 A huge thanks to my co-authors Selim Tümkaya, Bengü Yücens, Mohamed Gunduz and Maxime Maheu @maheump.bsky.social
In sum :
✅ Consciousness disruption translates into various symptomatic expressions according to the psychiatric disorder
✅ In patients with OCD, consciousness disruption delineates two distinct subgroups in terms of cognitive deficits and clinical features
‼️ Patients with SCZ have consciousness disruption in relation with positive symptoms
‼️ Patients with OCD who have a poor insight exhibit similar consciousness deficits as patients with schizophrenia
‼️ Patients with OCD and good insight performed similarly to controls ⤵️
We compared consciousness measures in patients with #OCD and with #schizophrenia as a function of symptom relevant dimensions.
😮 We found pretty surprising results: ⤵️
🗞️ First article as #lastauthor published in Neuroscience of Consciousness @nconsc.bsky.social 🥳 🥳 🥳
academic.oup.com/nc/article/d...
🔍 In this study, we examine how #consciousness disruption translates into clinical manifestations in different #psychiatric disorders. 🧶⤵️
Berko on air de bon matin sur @franceculture.fr
www.radiofrance.fr/francecultur...
Thanks to all my collaborators!!
Overall, our results underscore that a univariate data-driven symptom improvement measure can be more sensitive to detect antidepressant action and is specifically associated with baseline neurobehavioral features.
Moreover, improvement was more robustly predicted by baseline neural and clinical features under antidepressant compared to placebo.
However, the intensity of antidepressant and placebo response significantly differs (in previous papers on this dataset, scale level measures of improvement could not distinguish between the two).
We applied principal component analysis (PCA) on the variations of items from multiple clinical scales and strikingly observed a similar pattern of clinical improvement across antidepressant and placebo arms.
We explored clinical response in patients with major depressive disorder from the EMBARC dataset.
New paper out in Psychological Medicine where we found that #sertraline and #placebo strikingly induce a similar clinical improvement predicted by distinct neural configurations!
doi.org/10.1017/S003...
A big thank to my colleagues Baptiste Fauvel, @katrinpreller.bsky.social and Raphaël Gaillard
Please find here the link for free access until 27th of July:
authors.elsevier.com/a/1lE1NY3M3l...
Enjoy!!
🧠 No fewer than 81 articles are described in depth and put together to provide an overview of the neurocognitive effects of psilocybin in healthy volunteers and people with medical conditions.
😅 Believe me, it was quite a long journey before it was published in Neuroscience & Biobehavioral Reviews!
📚 Just another #review about #psychedelics? Maybe... but in this paper we systematically reviewed ALL neuroimaging articles involving #psilocybin intake in humans.
www.sciencedirect.com/science/arti...